Barclays Thinks Ionis Headed Toward a $106 Target This Year
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
Budget calculator numbers can be opaque. Learn what they mean and how to translate them into concrete next steps.
17,691 articlesBarclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
A Goldman Sachs trading desk note argues that heavy institutional deleveraging has run its course, suggesting a poten...
Lean In is undergoing a major overhaul, including a 25% staff reduction and a new CEO, as it pivots to engage with tr...
The Nasdaq has slipped into correction territory, raising questions about the next move. This guide uncovers historic...
As factories re-shore production in 2026, three ETFs track the trend with different tilts. Here is how AIRR, PAVE, an...
Andreessen Horowitz's crypto unit closes its fifth fund at $2.2 billion, signaling a patient, long-horizon bet on cry...
A Nurix Therapeutics insider recently sold shares, drawing attention from investors. This article breaks down the mov...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
Schd: dividend that delivers is more than a catchy phrase—it reflects a disciplined strategy focused on high-quality ...
Two Dividend Kings anchor Berkshire Hathaway's core holdings as Greg Abel takes the helm. Analysts say Coca-Cola and ...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
GoMining unveils a base-layer Bitcoin payments protocol designed for instant settlements and everyday purchases, plus...